Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use

Details for Australian Patent Application No. 2001245836 (hide)

Owner Bristol-Myers Squibb Company

Inventors Albright, Charles F.; Copeland, Robert A.; Dimeo, Susan V.; Yue, Eddy W.; Huang, Pearl S.; Higley, C. Anne; Han, Wei; Graciani, Nilsa R.; Dowling, Radine L.; Combs, Andrew P.

Agent Callinan

Pub. Number AU-A-2001245836

PCT Pub. Number WO01/68145

Priority 60189387 15.03.00 US

Filing date 15 March 2001

Wipo publication date 16 July 2002

International Classifications

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 035/00 Antineoplastic agents

A61K 031/704

Event Publications

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

1 July 2004 Application Open to Public Inspection

  Published as AU-A-2001245836

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001245837

2001245835